Answers are grounded in this paper and cite their sources.
CASPR2-associated neurological diseases cover a broad clinical spectrum, with limbic encephalitis and Morvan syndrome representing the most characteristic autoimmune phenotypes. We report the case of a 2-year-old boy who presented with abdominal and generalized pain, refusal to eat or drink, weight loss, loss of mobility, and behavioral changes, including sleep disturbances. Further clinical evaluation revealed pharmacoresistant arterial hypertension and hyperhidrosis. Extensive diagnostic testing excluded infectious and toxic causes. CASPR2 antibodies were detected in both serum and cerebrospinal fluid. Initial therapy with corticosteroids and intravenous immunoglobulins resulted in only minimal clinical improvement. Significant clinical recovery was only achieved after escalation of immunotherapy with plasmapheresis and subsequent B-cell–depleting therapy with rituximab. At the most recent follow-up visit, seven months after the first rituximab infusion, the patient showed complete recovery without residual symptoms. This case underscores the diagnostic challenges of CASPR2-associated autoimmunity in early childhood and highlights the importance of early recognition of this rare but treatable disease.
No takes yet. Share an insight, caveat, or question.
Ehl et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: